Dashboard
Manage Tickers

MGRX MANGOCEUTICALS, INC.

Nasdaq www.mangorx.com


$ 2.33 $ -0.02 (-0.85 %)    

Friday, 24-Oct-2025 13:55:41 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 618.09 $ 2.09 (0.34 %)
DIA $ 472.70 $ 2.82 (0.6 %)
SPY $ 678.09 $ 1.66 (0.24 %)
TLT $ 91.53 $ -0.04 (-0.04 %)
GLD $ 378.11 $ -0.47 (-0.12 %)
$ 2.32
$ 2.34
$ 2.28 x 900
$ 2.34 x 400
$ 2.30 - $ 2.50
$ 1.32 - $ 6.15
183,928
na
24.44M
$ -1.45
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-20-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-01-2024 12-31-2023 10-K
8 10-27-2023 09-30-2023 10-Q
9 07-28-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Consumer Staples Stocks Moving In Tuesd...
10/21/2025 21:06:27

Core News & Articles
12 Consumer Staples Stocks Moving In Tuesd...
10/14/2025 21:06:11

mangoceuticals-q2-eps-057-up-from-135-yoy-sales-168109k-up-from-163163k-yoy
Mangoceuticals Q2 EPS $(0.57) Up From $(1....
08/14/2025 20:54:09

Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.57) per share. This is a 57.78 percent increase over losses of $(...

mangoceuticals-entered-into-mutual-rescission-and-release-agreement-with-navy-wharf-to-terminate-and-rescind-msa
Mangoceuticals Entered Into Mutual Resciss...
08/04/2025 13:20:56

-SEC Filing

Core News & Articles
12 Consumer Staples Stocks Moving In Thurs...
07/17/2025 21:05:54

mangoceuticals-files-for-mixed-shelf-of-up-to-150m
Mangoceuticals Files For Mixed Shelf Of Up...
06/13/2025 20:45:14

-SEC Filing

mangoceuticals-files-for-resale-up-to-45m-shares-of-common-stock-by-selling-shareholders
Mangoceuticals Files For Resale Up To 4.5M...
05/30/2025 20:42:08

 - SEC Filing 

mangoceuticals-announces-results-from-field-studies-showing-100-respiratory-survival-in-poultry-studies
Mangoceuticals Announces Results From Fiel...
05/27/2025 13:08:26

mangoceuticals-enters-intellectual-property-purchase-agreement-to-acquire-intellectual-property-product-formulations-know-how-distribution-supplier-relationships-and-related-assets-of-smokeless-technology-corp-terms-not-disclosed
Mangoceuticals Enters Intellectual Propert...
04/25/2025 13:03:52

mangoceuticals-entered-into-master-distribution-agreements-to-secure-exclusive-licensing-and-distribution-rights-for-diabetinol-within-us-and-canada
Mangoceuticals Entered Into Master Distrib...
03/25/2025 13:09:01

Diabetinol® is a clinically supported and patented plant-based nutraceutical product targeting the pre-diabetic and weight loss...

12-consumer-staples-stocks-moving-in-fridays-after-market-session
12 Consumer Staples Stocks Moving In Frida...
03/21/2025 21:05:45

mangoceuticals-launches-its-peachesrx-womens-telehealth-brand
Mangoceuticals Launches Its PeachesRx Wome...
02/20/2025 12:15:00

mangoceuticals-announces-advancement-in-avian-flu-prevention-with-water-based-antiviral-for-poultry-using-patented-technology-from-intramont-efficacy-demonstrated-in-phase-i-animal-studies-now-entering-phase-ii
Mangoceuticals Announces Advancement in Av...
02/12/2025 13:01:44

Mangoceuticals, Inc. (NASDAQ:MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, market...

mangoceuticals-announced-significant-progress-in-its-ongoing-h1n1-efficacy-study-conducted-by-vipragen-biosciences-an-aaalac-accredited-preclinical-cro-in-mysuru-india-on-its-patented-respiratory-illness-prevention-technology-in-collaboration-with-intramont-technologies-inc
Mangoceuticals Announced Significant Progr...
02/06/2025 12:12:27

mangoceuticals-announces-exclusive-distribution-agreement-with-propre-energie-for-dermytol-plant-based-skincare-proven-to-address-hyperpigmentation-and-acne-scars
Mangoceuticals Announces Exclusive Distrib...
02/03/2025 13:37:52

Mangoceuticals, Inc. (NASDAQ:MGRX), a company focused on developing, marketing, and selling a variety of men's wellness pro...

mangoceutical-announced-that-it-has-launched-an-investigation-into-potential-stock-manipulation-related-to-and-following-its-recent-reverse-stock-split-which-was-effective-as-of-october-16-2024
Mangoceutical Announced That It Has Launch...
12/04/2024 12:08:34

mangoceuticals-regains-full-compliance-with-nasdaq-minimum-bid-price-requirement
Mangoceuticals Regains Full Compliance Wit...
10/31/2024 12:39:55

Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, an...

mangorx-announces-that-it-has-initiated-a-process-to-evaluate-potential-strategic-alternatives-with-the-intent-to-unlock-and-maximize-shareholder-value-including-but-not-limited-to-potential-mergers-acquisitions-divestitures-and-business-combinations-acquisitions-of-businesses-entry-into-new-lines-of-business-business-expansions-joint-ventures-and-other-key-strategic-transactions-outside-the-ordinary-course-of-the-companys-current-business
MangoRx Announces That It Has Initiated A ...
10/22/2024 12:20:01

Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, an...

Core News & Articles
Mangoceuticals Says It Learned Earlier Thi...
10/21/2024 21:14:14

MangoRx strongly refutes any and all claims made by Eli Lilly regarding the sale of compounded tirzepatide. MangoRx believes it...

top-3-risk-off-stocks-which-could-rescue-your-portfolio-this-quarter
Top 3 Risk Off Stocks Which Could Rescue Y...
10/17/2024 11:18:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION